| treprostinil palmitil inhalation (INS1009) / Insmed |
2022-001950-45: A study to evaluate the effects of Treprostinil Palmitil Inhalation Powder in participants with Pulmonary Hypertension with Interstitial Lung Disease Estudio para evaluar los efectos de treprostinil palmitilo en polvo para inhalación en pacientes con hipertensión pulmonar asociada a enfermedad pulmonar intersticial |
|
|
| Ongoing | 2/3 | 32 | Europe | Treprostinil Palmitil Inhalation Powder, INS1009, Inhalation powder | Insmed Incorporated, Insmed Incorporated | Pulmonary Hypertension Associated with Interstitial Lung Disease Hipertensión pulmonar asociada a enfermedad pulmonar intersticial, Participants with high blood pressure in the arteries of the lungs Participantes con presión alta en las arterias pulmonares, Diseases [C] - Respiratory Tract Diseases [C08] | | | | |
NCT05649722 / 2022-001950-45: An Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) for Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) |
|
|
| Recruiting | 2/3 | 32 | Europe, RoW | Treprostinil Palmitil Inhalation Powder, INS1009, Placebo | Insmed Incorporated, Insmed Incorporated | Pulmonary Hypertension, Interstitial Lung Disease | 03/26 | 03/26 | | |
| Recruiting | 2/3 | 100 | Europe, Japan, US, RoW | Treprostinil Palmitil, INS1009, Placebo | Insmed Incorporated, Insmed Incorporated | Pulmonary Arterial Hypertension | 12/26 | 12/26 | | |
2021-001528-16: A study to evaluate the effects of Treprostinil Palmitil Inhalation Powder in participants with Pulmonary Arterial Hypertension. Estudio para evaluar los efectos de treprostinil palmitilo en polvo para inhalación en pacientes con hipertensión arterial pulmonar |
|
|
| Not yet recruiting | 2 | 99 | Europe | Treprostinil Palmitil Inhalation Powder, INS1009, Inhalation powder | Insmed Incorporated, INSMED INCORPORATED, Insmed Incorporated | Participants with Pulmonary Arterial Hypertension Pacientes con hipertensión arterial pulmonar, Participants with high blood pressure in the arteries of the lungs Pacientes con tensión sanguínea alta in las arterias de los pulmones, Diseases [C] - Respiratory Tract Diseases [C08] | | | | |
2021-003294-66: A study to evaluate the effects of Treprostinil Palmitil Inhalation Powder in participants with Pulmonary Hypertension with Interstitial Lung Disease Estudio para evaluar los efectos de treprostinil palmitilo en polvo para inhalación en pacientes con hipertensión pulmonar asociada a enfermedad pulmonar intersticial |
|
|
| Not yet recruiting | 2 | 32 | Europe | Treprostinil Palmitil Inhalation Powder, INS1009, Inhalation powder | Insmed Incorporated, INSMED INCORPORATED, Insmed Incorporated | Pulmonary Hypertension Associated with Interstitial Lung Disease Hipertensión pulmonar asociada a enfermedad pulmonar intersticial, Participants with high blood pressure in the arteries of the lungs Pacientes con presión alta en las arterias pulmonares, Diseases [C] - Respiratory Tract Diseases [C08] | | | | |
NCT05176951: A Study to Evaluate the Safety and Tolerability of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease |
|
|
| Completed | 2 | 39 | Europe, RoW | Treprostinil Palmitil, INS1009, Placebo | Insmed Incorporated | Pulmonary Hypertension | 03/24 | 03/24 | | |
NCT05147805: A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Arterial Hypertension |
|
|
| Recruiting | 2 | 99 | Europe, Japan, US, RoW | Treprostinil Palmitil, INS1009, Placebo | Insmed Incorporated | Pulmonary Arterial Hypertension | 07/25 | 07/25 | | |
NCT06091579: A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Treprostinil Palmitil Inhalation Powder (TPIP) in Healthy Participants |
|
|
| Completed | 1 | 42 | US | Treprostinil Palmitil Inhalation Powder, INS1009, Placebo | Insmed Incorporated | Healthy Volunteers | 01/21 | 01/21 | | |
